- Published at
- by seekingalpha.com
mixed
mixed
Eleison Pharmaceuticals: Betting On Late-Stage Candidates For Orphan Diseases (ELSN)
Eleison Pharmaceuticals acquires, develops and commercializes late-stage therapies for orphan diseases with unmet needs. Read our analysis on ELSN here.